son with normals (172 +14); these differences reflected the different basal plasma insulin concentrations in these three groups. Chronic treatment with oral hypoglycemic drugs, age, duration of the disease, and degree of metabolic control appeared to have only little effect on the kinetics of insulin. On the basis of these results, we conclude that insulin-independent adult diabetics show, already in the fasting state, a combination of insulin resistance and insulin deficiency and a derangement in insulin distribution, the precise significance of which is uncertain.
A B S T R A C T The studies so far reported on the metabolic clearance rate of insulin in human diabetes mellitus have given conflicting results, probably because they have been conducted on few patients and have used a variety of experimental techniques and data treatments. We investigated the kinetics of insulin distribution and degradation in 35 normal subjects and in 42 nonketotic, nonobese, overtly diabetic patients, of whom 26 were above 40 yr old and 16 were 40 yr old or less at diagnosis. The design of the study combined (a) the use of a tracer to perturb minimally the steady state and to avoid glucose infusion; (b) the preparation of purified [125I]_ monoiodoinsulin, which has a metabolic behavior similar to that of native insulin; and (c) noncompartmental analysis of the plasma immunoprecipitable 125I-insulin disappearance curves, which were recorded for 2 h after pulse i.v. injection of the tracer.
Metabolic clearance rate was found to be similar in diabetics (404±18 ml/min m2, mean+SEM) and in normals (420+14), although the latter-onset patients had slightly, if not significantly, lower metabolic clearance rate values than the earlier-onset diabetics (385+19 and 443+36, respectively). The initial distribution volume of the hormone also did not significantly differ in diabetics and normals and was similar to plasma volume. The reentry rate into the initial distribution volume of the hormone and the total, plasma-equivalent distribution volume of insulin were both significantly raised in diabetics (251 +±12 ml/minm and 10.3+0.5 liters/M2) in comparison with normals (195+8 and 7.5±0.3). The posthepatic delivery rate of insulin was found to be slightly raised in lateronset diabetics (194+±20 mU/h im2), but somewhat reduced in earlier-onset diabetics (133+15) in compari-
INTRODUCTION
Although the metabolic clearance rate (MCR)l of insulin in human diabetes mellitus has been measured by several investigators, the results have been conflicting, because normal (1), slightly increased (2) , and decreased (3, 4) MCR values have all been reported. It is clearly difficult to compare the studies so far available, because of the considerable differences in the criteria for selecting the diabetic patients, in the experimental techniques used, and in the modes in which the data were analyzed. Such discordant findings suggest that the removal of insulin from diabetic plasma does not differ greatly from normal, because otherwise, this would have been clearly detected by these studies. A kinetic study, however, can give more information than just the degradation rate, by providing estimates of the quantity of insulin in body compartments which are not accessible to direct measurement. In this way, it has been shown that, in the normal subject, glucose utilization reflects the timecourse of insulin concentration in a slowly equilibrating compartment, apparently representing the interstitial fluid of muscle and adipose tissue (5) . It seemed, therefore, of interest to study the kinetics of insulin in diabetics, in whom there is a substantial impairment of insulin action on muscles and fat, possibly caused by receptor failure (6, 7) .
We obtained complete kinetic analyses in a large series of diabetic patients and in a similar number of healthy subjects used as the control group. Nonobese, nonketotic clinical diabetics were chosen because they were thought to represent the greater part of the diabetic population. The experimental approach included the use of purified [125I]monoiodoinsulin as a tracer for native insulin and noncompartimiental analysis (8) of the plasma disappearance curves.
The results showed that the MCR of insulin of these diabetic subjects was approximately normal, but the diffusion of the hormone out of the vascular compartment and its apparent distribution space were significantly, though not greatly, increased with respect to normal. Insulin resistance and relative insulin lack were also found to be associated with the fasting hyperglycemia of nonketotic diabetes mellitus.
METHODS
Patient selection. 42 diabetics who had never received insulin treatment were studied. Most of them were outpatients attending the Diabetic Unit. A thorough physical examination and a routine laboratory checkup were performed before the study, and only those patients who showed no evidence of other systemic or parenchymal diseases were included in the study. The pertinent clinical data are given in Table I ; none of the patients had ketone bodies in the urine when the study was conducted. A regulation index (RI, see legend to Table I) was calculated by including all relevant data available from the patients' clinical records from 1 yr before to 6 mo after the study. In most study subjects, the metabolic status, evaluated in this way, was reasonably well controlled. 34 (14) . By all these procedures, the labeled protein was split from the unreacted iodine, as shown by paper electrophoresis. Insulin concentration in the elution fractions was measured by ultraviolet absorbance at 277.5 nm, or by a radioimmunoassay with 131I-insulin as the labeled antigen (15) . The specific activity of the tracer, estimated in these ways, was 8-10 mCi/mg when 1251-insulin was purified on Sephadex G-50, and ranged from 100 to 200 mCi/mg when ion-exchange chromatography was used. 40% of the normal subjects and 33% of the diabetic subjects received the high specific activity tracer.
Monoiodotyrosine (MIT) and diiodotyrosine (DIT) were estimated on representative samples of the protein peak according to Covelli Kinetics of Insulin Disappearance in Diabetes Mellitus(dilution 1:500) were added to 1251-insulin-containing plasma samples, and the antigen-antibody complexes were then precipitated with rabbit anti-guinea pig gamma globulins. The precipitated complexes were collected by centrifugation at 3,000 g and counted in a well-type gamma counter (Nuclear Chicago Corp., Des Plaines, Ill.; efficiency 40%). Blank values were obtained in duplicate for each sample by substituting normal guinea pig serum for the anti-insulin antibody in the incubation mixture; the radioactivity precipitated under these conditions (2-3% on average) was considered to be nonspecific and was therefore subtracted from the specific precipitated counts. Immunoprecipitability ranged from 90 to 95% of the injected dose and of the plasma samples collected soon after injection. Since in the late samples of the 1251-insulin curve the immunoprecipitable fraction was usually about 100 times less than in the early readings (Fig. 4) , the nature of the nonimmunoprecipitable radioactivity was assessed by paper electrophoresis in 10 normal subjects and 10 diabetics. It was found that, both in normals and in diabetics, about 60% of the radioactivity was free iodine and about 38% had a molecular weight lower than insulin, presumably representing its degradation products.
The existence of cross-reaction between 125I-insulin and its degradation products was also assessed. A and B chains, obtained by sulfitolysis of tracer insulin and purified on 50X2 Dowex, and A chain fragments, produced by enzymatic hydrolysis ofthe A chain with a-chymotrypsin, were added to normal serum and processed in the same run with samples containing undegraded 1251-insulin. Coprecipitation was found to be 0.09% and 0.47% for the A and B chain, respectively, and null for A chain fragments.
Plasma concentration of endogenous insulin (IRI) was measured with 1311-insulin as labeled antigen (prepared by the same procedure described for 1251-insulin) and dextrancoated charcoal and centrifugation at 3,000 g for separating bound from free insulin. The inter-and intra-assay coefficients of variation were 14 and 7%, respectively (18) , in the range of the basal concentrations (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) ,uU/ml). 
DATA ANALYSIS
The kinetic parameters were computed from the plasma disappearance curve P(t) of immunoprecipitable 1251-insulin with a minimum assumption model ( Fig. 1) , which has been applied in the analysis of the kinetics of a great number of blood-borne compounds (19, 20 
mU/M2) =TDV * IRI (12) The above equations are correct given the following assumptions: (a) that the sytem is linear and time-invariant for the duration of the experiment; (b) that the tracer is injected at the same site as that where the tracee enters the system; and (c) that all catabolism (or irreversible loss) occurs in sites whose exchange rate with the central pool is so high that they are practically indistinguishable from it. Assumption (a) implies that the subject is in steady-state conditions for the duration of the experiment (2 h in the studies here reported). Peripheral plasma IRI concentrations were stable, within the limits of the experimental error of the measurements, in our shortly (overnight) fasted subjects. On the other hand, when low specific activity tracer was used, nonnegligible amounts of cold insulin were administered, 3D indicates the immunoprecipitable fraction of the administered dose. The values of k, i,, and T, are not reported in this paper, because they add little to the information conveyed by other parameters.
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R. Navalesi (5), who have shown that the IRI curves obtained after infusing double amounts of unlabeled hormone were essentially the same, apart from a scale factor, within the range of the physiological concentrations. Assumption (b) is not fulfilled in the kind of experiment described here, where the tracer is administered via a peripheral vein. In fact, endogenous insulin must pass through the liver before being mixed in peripheral plasma. Since it is known (22) that the liver retains considerable amounts of insulin, the peripheral injection of the tracer is actually capable of tracing only that fraction of the hormone which survives the first transhepatic passage (23, 24) . As a consequence, the values of turnover rate reported in this study, referred to as insulin delivery rate (IDR), represent the basal posthepatic delivery rate of insulin.
Assumption (c) implies that all insulin molecules eventually return to the central compartment before being degraded. However, it can also be postulated that insulin is irreversibly removed also by sites (organs and tissues) whose exchange rate with plasma is slow in comparison with the turnover rate of the hormone (5, 25) . The consequences of assuming peripheral catabolism are the following: (a) Eq. 2 will still provide a correct estimate of the overall clearance rate, but the relative amounts of the central and peripheral catabolism remain undetermined. (b) The RR values derived from Eq. 5 will not be an estimate of the diffusion of insulin out of IDV, as it would be if all catabolism were central, but will be PLASMA GLUCOSE Both in normals and in diabetics, the coefficients of variation ranged from 1.8% to about 18% for the samples taken at 2 and 120 min, respectively, and varied linearly in between. This estimate of the variance was then used in a Monte Carlo simulation: randomly generated numbers, normally distributed with zero as the mean and the variance computed as above, were added to the mean population curves and the kinetic parameters were calculated. This procedure was iterated 1,000 times, and the standard deviations and coefficients of variation were computed for each parameter (Table II) . It can be seen that the uncertainty of the variables requiring the extrapolation of the time x concentration function (t and TDV) was considerably higher than that of the other parameters, and more so for the diabetic population curve, which had a slower final slope. Obviously, however, these coefficients of variation were invariably smaller than those found experimentally (Table III) , because the latter included the individual variability.
Comparison of the means was performed by Student's t test or, where variances were different (Fisher's F) at the 5% level of significance, by the Behrens test (26) .
RESULTS
Fig . 4 shows the mean plasma disappearance curves of the immunoprecipitable and the nonimmunoprecipitable radioactivity for both the normal and the diabetic group studied.
In Table III , the mean values for the kinetic parameters of the normal and the diabetic subjects are reported, together with the significance ofthe differences between the means. 4 The IDV was similar in normals and diabetics (51 and 49 ml/kg, respectively), and about 20% larger than plasma volume as measured by radioiodinated albumin [40-50 ml/kg (27) ]. This difference is explained by the fact that, in the case ofinsulin, before mixing in plasma is complete (2-3 min), some extravascular diffusion and some degradation occur, whereby the computed zerotime concentration is lower. The ER and the MCR did not differ in the two groups, but diabetics had higher (25%) RRs and more recycles of insulin through plasma (v). Also, the mean residence time (1) was longer in diabetics, and consequently, their TDV was expanded, by about 37% on average, over that of normals. The IRI and (IDR) did not differ, but the BIM was about 1Y2 times as great in diabetics as in nondiabetics. 4 The individual values of these kinetic variables are deposited with the National Auxiliary Publications Service.
See footnote 2. Although acute i.v. injection of tolbutamide has been shown to produce no alteration of radioinsulin clearance (1), it is possible that chronic treatment with hypoglycemic agents might do so. Therefore, eight diabetic patients controlled by diet only were also studied. These patients (Table IV) the follow-up of these patients' disease confirmed that in the subgroup of later-onset subjects there were only classical maturity-onset diabetics. The younger subgroup, however, contained seven patients with maturity-onset-type diabetes in youth and nine patients who, although free from ketosis at the moment of the kinetic study, required insulin a few weeks afterwards.
The direct comparison (Table V) of these two subgroups showed that the younger patients had had the disease for a shorter time (P < 0.05), were in worse metabolic control (RI) (P < 0.05), and had lower fasting plasma insulin levels (P <0.01) and delivery rates (P < 0.05) than the older group. However, when each of these two subgroups was compared with the control group, the same differences were found in the kinetic parameters as those existing between the group of all diabetics and normals, with the exception of BIM, which was not significantly larger in the earlier-onset patients than in the controls.
Thus, the age of onset of diabetes was only clearly reflected in those parameters (IDR and BIM) that depend on insulin concentration, although IDV, ER, RR, and MCR revealed a trend toward being higher in the younger than in the maturity-onset diabetic subjects.
In comparing the 26 later-onset patients (mean age 54.5 yr) with the control group (mean age 36.4 yr), mismatching for age was a concern. The nondiabetic subjects were therefore subdivided into two subgroups according to their age. No differences, however, could be found in any of the kinetic variables between the 24 subjects under 40 and the 11 over 40 yr of age, or between each of these subgroups and any of the groups of diabetics. In addition, in the normals, none of the kinetic parameters was correlated with age.
Effect ofage, weight, duration ofdiabetes, metabolic The reported levels of significance refer to the comparison with the group of 35 normal subjects. Lower levels of circulating insulin were found to be significantly associated with higher ER (r = 0.50, P < 0.001), MCR (r = 0.39, P < 0.05), and RR (r = 0.38, P < 0.05) of the hormone.
The overall picture which these relationships suggest is that mature, longer-term, well-controlled diabetics have more circulating insulin but slower flow rates (ER, MCR, and RR) than their younger, recently diagnosed counterparts with less satisfactory metabolic balance. These findings are similar to those emerging from the comparison of the two subgroups of diabetics in Table V. Interrelationship ofthe kinetic variables. MCR was highly significantly (P < 0.001) related to RR in a direct fashion in the control subjects, but not in diabetics (Fig. 5) . In fact, the mean number of recycles of insulin in its IDV (v = RR/MCR) was relatively constant in the normal subjects (coefficient of variation 23%), but was more scattered in diabetics (coefficient ofvariation 42%), suggesting that the two groups under study were, with regard to this variable, separated.
A strong (P < 0.001) positive correlation was found to exist between RR and TDV, both in normals and in diabetics (Fig. 6) .
DISCUSSION
The validity of iodoinsulin as a tracer for native insulin has been repeatedly questioned (31, 32) . Lower values for MCR have been reported by those investigators (1, 33, 34 ) who used tracer radioinsulin in comparison with the findings of those (1, 5, 35) who employed cold insulin (Table VI) . On the contrary, in the present study, we report that the MCR of 125I-insulin in 35 healthy subjects was found to be 727 ml/min-1.73 m2, a figure that compares well with the 780 ml/min-1.73 m2 reported by Sherwin et al. (5), and the 860 ml/min obtained by Genuth (1), with unlabeled hormone. The inconsistency between our results with tracer insulin and those previously published could be explained by differences in the quality ofthe radioinsulin employed. Indeed, in our preparations, the iodination degree was kept as low as 0.05 iodine atoms per molecule on average, and the labeling mixture was always purified to take out overiodinated species. It is established, in fact, that the rate and extent of degradation of iodoinsulins are inversely related to the iodination degree (36, 37) . Lightly iodinated insulin, on the other hand, retains full immunological reactivity (32, 38) , biological activity (32, 14) , and binding to membrane receptors (13) and is efficiently degraded by fat (39) and liver (37, 40) cells.
Direct evidence bearing on this point is provided by the experiments reported in Table VII : When two subjects were first given lightly iodinated radioinsulin and then a mixture containing over 30% DIT, MCR fell by roughly 30%. In addition, if one compares the plasma disappearance of cold insulin, recorded in 10 study subjects who received low specific activity tracer (Fig. 3) , with the decay of 125I-insulin (Fig. 4) , it can be seen that both decline with a half-time of about 3 min; furthermore, the MCR computed by monoexponential interpolation of the experimental points of the first 15 min is 460 ml/min m2 for cold insulin, and 440 for radioactive insulin. Thus, at least during this initial period, the labeled and the unlabeled molecules were being handled indistinguishably by the same subject.
Although there are sufficient grounds to conclude that [125I]monoiodoinsulin and exogenous unlabeled insulin have substantially the same behavior, the validity of applying the results of the present kinetic analysis to the endogenous, biologically active hormone could still be questioned. In particular, it could be supposed that the long "tails" of the plasma decay curves, emerging about 30 min after injection when the radioactivity is less than 3% of its initial value, are due to a labeled, partially degraded derivative of the tracer, which, though still immunoreactive, is cleared from plasma at a slower rate than insulin itself. In this case, the larger tail areas of diabetics, which generated prolonged residence times in the computation, could simply reflect the accumulation of this derivative, consequent to its The cases identified as "bis" are the studies where heavily iodinated insulin was injected.
slower clearance in these patients in comparison with the normal subject. Such a derivative, however, should not be the free A or B chain, since neither is immunoreactive (and labeled A or B chains did not appreciably coprecipitate in our immune assay system).
In addition, it can be presumed that the putative derivative would be produced not only from iodinated insulin but also from cold insulin, because the 1251_ insulin curves of our normal subjects and those computed by Sherwin and co-workers (5) RR reflects the extravascular diffusion on insulin on the condition that IDV represents the intravascular space and that all catabolism is central (see Data Analysis). RR will then be related to plasma volume, to the permeability of the capillary membranes, and to the pressure gradients across them. According to this line of reasoning, the correlation between RR and MCR (Fig. 5) can be interpreted as evidence that the rate of insulin degradation is also dependent on the amount of it that is made available to the degradative sites through diffusion. This relationship was lost in diabetics, who, on average, had significantly higher RR than normal. This could be explained by an increased capillary permeability in our diabetics. With regard to this possibility, there is evidence to show that diabetes is associated with increased permeability and increased hydrostatic pressure in the microcirculation, resulting in an abnormal extravasation of plasma proteins (45) . Increased transcapillary escape rates of albumin and globulins have been found both in long-term diabetics (45) and, more recently, in short-term juvenile diabetics in poor metabolic control (46) , and have been connected with diabetic microangiopathy. In particular, in our group of younger, less well-controlled diabetics (Table V) , RR was raised even more than in older diabetics, suggesting that hyperglycemia itself or hypoinsulinemia (or both) may play a role (47) .
It should also be noted that, if peripheral catabolism is assumed to exist, the rise in RR could also be accounted for by the concomitant reduction in MCR (as was the case for our later-onset patients [ Table V ]), which would thus contribute to increase the rate of return of insulin to plasma through lymph (48 (27) ; (b) the TDV of insulin is plasma-equivalent, and therefore, it reflects not only the physical distribution space but also possible concentration gradients between the intra-and the extravascular pool; and (c) the estimates of TDV, obtained with our model, are the minimal possible; in fact, if some degradation is assumed to occur in slowly exchanging degradative sites, the distribution volume of the molecules leaving but not returning to plasma should be added. According to these considerations, the expanded TDV of the diabetic patients, which has been found also by Frost et al. (3) , admits several explanations: (a) The physical distribution space, i.e., the extracellular fluid, is enlarged; (b) the increase in the exchangeable TDV is only apparent, resulting from reduced degradation rate at sites which slowly equilibrate with plasma; and (c) the ratio of the mean extravascular to the intravascular concentration of insulin is increased. With reference to the first explanation, there is some evidence (49) that blood volume and, possibly, the extracellular fluid are elevated in uncontrolled but nondehydrated diabetics, as an osmotic effect of hyperglycemia. This effect alone, however, is not enough to account for the over 5 liters of excess TDV of our patients (50) . In addition, their plasma glucose levels were only moderately raised, and ketone bodies were absent.
Considering the second explanation, it has been shown that insulin is cleared also in slowly equilibrating tissues, such as skin, muscle, and fat (5, 25) , and that its clearance by the forearm is reduced in diabetics (25) . However, as we measured essentially normal overall clearance rates in diabetics, no inference concerning the relative entities of peripheral vs. central degradation rates can be made.
Lastly, with regard to the third hypothesis, since the extravascular concentration of a protein is also dependent on its rate of egress from plasma (51), a raised TDV could simply mean that more insulin is accumulated in the extravascular space of diabetics as a result of increased RR. This would explain the observed correlation between RR and TDV (Fig. 6) .
It must be said that all these interpretations are compatible with the kinetic results presented here, but their likelihood, magnitude, and pathophysiological relevance should be examined by other experimental approaches. Maturity-onset patients delivered about 8 U of insulin per day into the systemic circulation under basal conditions, in accordance with previous estimates (1, 5, 52, 53) . This delivery was slightly higher than normal and, in the presence of raised plasma sugar, means that insulin-independent diabetics have tissue resistance to the action of insulin already in the postabsorptive state and produce less insulin in response to the hyperglycemic stimulus than normals would do. The IDR figure for the younger patients (5.5 U/day), on the other hand, shows that they were suffering from some insulin lack.
In conclusion, although insulin degradation is es- 
